Evidence map›Paper›PMID 40934260›Full record

ArticlePLoS pathogens2025

HIV-1 Tat favors the multiplication of Mycobacterium tuberculosis and Toxoplasma by inhibiting clathrin-mediated endocytosis and autophagy.

Aurélie Rivault, Audrey Bernut, Myriam Ben-Neji, Magali Abrantes, Maxime Jansen, Sylvaine Huc-Brandt, Sébastien Besteiro, Yann Bordat, Mai Nguyen-Chi, Nelly Audemard and 7 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Aurélie RivaultInstitut de Recherche en Infectiologie de Montpellier, Université de Montpellier, CNRS, Montpellier, France.
Audrey BernutLaboratory of Pathogens and Host Immunity, Université de Montpellier, CNRS, INSERM, Montpellier, France.
Myriam Ben-NejiInstitut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, Toulouse, France.
Magali AbrantesInstitut de Recherche en Infectiologie de Montpellier, Université de Montpellier, CNRS, Montpellier, France.
Maxime JansenInstitut de Recherche en Infectiologie de Montpellier, Université de Montpellier, CNRS, Montpellier, France.
Sylvaine Huc-BrandtLaboratory of Pathogens and Host Immunity, Université de Montpellier, CNRS, INSERM, Montpellier, France.
Sébastien BesteiroLaboratory of Pathogens and Host Immunity, Université de Montpellier, CNRS, INSERM, Montpellier, France.
Yann BordatLaboratory of Pathogens and Host Immunity, Université de Montpellier, CNRS, INSERM, Montpellier, France.
Mai Nguyen-ChiLaboratory of Pathogens and Host Immunity, Université de Montpellier, CNRS, INSERM, Montpellier, France.
Nelly AudemardInstitut de Recherche en Infectiologie de Montpellier, Université de Montpellier, CNRS, Montpellier, France.
Margaux Mesleard-RouxInstitut de Recherche en Infectiologie de Montpellier, Université de Montpellier, CNRS, Montpellier, France.
David PerraisInterdisciplinary Institute for Neurosciences, Université de Bordeaux, CNRS, Bordeaux, France.
Olivier NeyrollesInstitut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, Toulouse, France.
Geanncarlo Lugo-VillarinoInstitut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, Toulouse, France.
Christel VérolletInstitut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, Toulouse, France.
Lucile EspertInstitut de Recherche en Infectiologie de Montpellier, Université de Montpellier, CNRS, Montpellier, France.
Bruno BeaumelleInstitut de Recherche en Infectiologie de Montpellier, Université de Montpellier, CNRS, Montpellier, France.ORCID 0000-0002-4912-9134

Funding

Agence Nationale de Recherche
6 · The paper itself

Abstract

HIV-1 and Mycobacterium tuberculosis (Mtb) coinfections are a major public health problem but are not well characterized. HIV-1 Tat is secreted by infected cells, generating nanomolar concentrations of Tat in the sera of people living with HIV. Circulating Tat enters cells, binds to PI(4,5)P2 then undergoes palmitoylation, thereby becoming resident on this phosphoinositide. Here, we found that Tat favors the multiplication of Mtb in macrophages. Moreover, Tat renders zebrafish larvae more sensitive to mycobacterial infection. We found that Tat binding to PI(4,5)P2 and palmitoylation enable Tat to inhibit the recruitment of the AP-2 adaptor, thereby inhibiting clathrin-mediated endocytosis and in turn autophagy. This inhibition prevents the degradation of intracellular pathogens such as Mtb and opsonized Toxoplasma gondii, but also of lipid droplets, thereby facilitating the access of these pathogens to lipids. We thus identified a mechanism enabling HIV Tat to favor the multiplication of intracellular pathogens such as Mtb.

Indexed as

AutophagyClathrinEndocytosisHIV-1HIV InfectionsMycobacterium tuberculosistat Gene Products, Human Immunodeficiency VirusToxoplasmaTuberculosisAnimalsHumansMacrophagesToxoplasmosisZebrafishClathrintat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID40934260
PMCPMC12445553

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.